The Health Ministry notified a ban on the manufacture for sale, sale and distribution for human use of 16 Fixed Dose Combinations (FDCs) under Section 26A of the Drugs and Cosmetics Act, 1940, with immediate effect (announced 20 June 2026).
The ban follows a Supreme Court-directed review in which an Expert Committee constituted by the Drugs Technical Advisory Board found these FDCs lacked therapeutic justification.
The 16 FDCs include six aloe-based skin preparations, analgesic-antispasmodic mixes and five antibiotic combinations, four of them paired with the enzyme serratiopeptidase.
FDCs prohibited under Section 26A, June 2026
| No. | Composition |
|---|---|
| Analgesic / antispasmodic | |
| 1 | Acetyl salicylic acid + Ethoheptazine |
| 8 | Dicyclomine + Paracetamol + Clidinium bromide |
| 9 | Dicyclomine + Paracetamol + Clidinium bromide + Chlordiazepoxide |
| 11 | Paracetamol + Lignocaine |
| Dermatological (aloe-based) | |
| 2 | Aloe extract + Allantoin + Alpha-tocopherol acetate + D-Panthenol + Vitamin A |
| 3 | Aloe extract + Vitamin E + Dimethicone + Glycerine |
| 4 | Aloe vera + Jojoba oil + Vitamin E |
| 5 | Aloe vera + Orange oil |
| 6 | Aloe vera + Jojoba oil + Wheat germ oil + Tea tree oil |
| 7 | Aloe vera + Vitamin E + Herbal |
| Anti-diabetic | |
| 10 | Gliclazide + Chromium picolinate |
| Antibiotic-based | |
| 12 | Amoxicillin + Serratiopeptidase + Lactobacillus sporogenes |
| 13 | Amoxicillin + Cloxacillin + Lactic acid bacillus + Serratiopeptidase |
| 14 | Amoxicillin + Serratiopeptidase |
| 15 | Cefadroxil + Probenecid |
| 16 | Cefuroxime + Serratiopeptidase |
Inserted by the 1982 amendment (Act 68 of 1982). Empowers the Central Government to prohibit manufacture, sale or distribution of a drug that risks harm, lacks its claimed therapeutic value, or contains ingredients without therapeutic justification.
The parallel Central power to prohibit IMPORT of such drugs in the public interest.
Constitutes the Drugs Technical Advisory Board, the statutory technical adviser to the Centre and States.
Statutory board under Section 5; the Supreme Court referred the FDC review to it in December 2017
National Regulatory Authority for drugs, under DGHS, MoHFW
Expert committee set up by MoHFW on 16 September 2014 to examine FDCs licensed without central approval; its findings led to the March 2016 ban of 344 FDCs
MoHFW constitutes the Kokate Committee
344 FDCs banned on Kokate Committee findings
Supreme Court refers the FDCs to DTAB for examination
328 FDCs banned on DTAB's recommendation
156 FDCs banned on Expert Committee advice
16 more FDCs banned
An FDC packs two or more active ingredients in a fixed ratio into one dose. It becomes 'irrational' when the combination adds no therapeutic benefit over single drugs but adds risk, as with antibiotics paired with an enzyme like serratiopeptidase.
GS Paper 2 > Health > Regulatory bodies and statutory framework
General Awareness > Government notifications
With reference to the Constitution of India, consider the following statements: 1. No High Court shall have the jurisdiction to declare any central law to be constitutionally invalid. 2. An amendment to the Constitution of India cannot be called into question by the Supreme Court of India. Which of the statements given above is/are correct?
Answer: Neither 1 nor 2
The power of the Supreme Court of India to decide disputes between the Centre and the States falls under its
Answer: original jurisdiction
Who/Which of the following is the custodian of the Constitution of India?
Answer: The Supreme Court of India
In India, Judicial Review implies
Answer: the power of the Judiciary to pronounce upon the constitutionality of laws and executive orders.
With reference to the Constitution of India, prohibitions or limitations or provisions contained in ordinary laws cannot act as prohibitions or limitations on the constitutional powers under Article 142. It could mean which one of the following?
Answer: The Supreme Court of India is not constrained in the exercise of its powers by laws made by the Parliament.
The Centre's power under the D&C Act to prohibit manufacture, sale and distribution of a drug in public interest.
Statutory technical board under Section 5, chaired by the DGHS.
Two or more active drugs in a fixed ratio in a single dosage form.